HDAC9 and melanoma: A CRISPR-Cas9 sgRNA knockout screen targeting chromatin factors in BRAFV600E melanoma cells in the presence of MAPKi rendered histone acetyltransferase (HAT) and deacetylase (HDAC) enzymes as hits [153,154].